Navigation Links
CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
Date:2/6/2008

Data also showed differences in gastrointestinal and lipid effects between

REYATAZ/ritonavir and lopinavir/ritonavir among study population

PRINCETON, N.J., Feb. 6 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced results from the CASTLE study, in which 300 mg of once-daily REYATAZ(R) (atazanavir sulfate) taken with 100 mg of ritonavir (REYATAZ/r) showed similar antiviral efficacy to twice-daily lopinavir 400 mg and ritonavir 100 mg (lopinavir/r) in previously untreated adult HIV-1 infected patients at 48 weeks, as part of HIV combination therapy. In this study, 78 percent of the 440 patients in the REYATAZ/r arm met the primary endpoint of achieving undetectable viral load (defined as HIV-1 RNA less than 50 copies/mL) at 48 weeks, compared with 76 percent of the 443 patients in the lopinavir/r arm.

CASTLE is the first large-scale, open-label, randomized study designed to demonstrate the non-inferiority of REYATAZ/r to lopinavir/r in previously untreated HIV-1 infected adult patients. Data from the CASTLE study were presented for the first time at the 15th Conference on Retroviruses and Opportunistic Infections (CROI) this week in Boston, Mass.

"The CASTLE study provides important additional data to inform the use of a once-daily regimen including REYATAZ and ritonavir in antiretroviral-naive HIV-infected patients," said Jean-Michel Molina, M.D., Hopital Saint Louis, Paris, France. "When choosing a treatment in previously untreated patients it is important to ensure antiviral activity as well as tolerability to optimize the management of HIV infection over the long term."

The most common grade 2-4 adverse events occurring in greater than or equal to three percent of patients
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Joslin Study Identifies Key Factor That Links Metabolic Syndrome; Finding May Help Millions at High Risk of Cardiovascular Disease
2. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
3. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
4. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
5. Inverseon Announces Positive Phase IIa Asthma Study
6. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
7. Study Says Allergy Shots Help Children, Reduce Health Care Costs
8. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
9. Mayo Clinic Study Finds Further Association Between Diabetes and Pancreatic Cancer
10. Divine Corporations Personal Lubricants Shown to Block Cancer-causing Viruses in a Study by the National Cancer Institute
11. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... (Nasdaq: LMNX ) today announced that it expects ... Monday, February 3, 2014. A press release announcing the results ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management will ... financial results for the fourth quarter and twelve months ended ...
(Date:1/14/2014)... Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company of ... Home Medical Equipment, Inc. ("Progressive") of Clarion, PA ... acquisition were not disclosed. Progressive is a ... range of sleep, mobility, and respiratory products to customers in ...
(Date:1/14/2014)... 2014   NuAire , a manufacturer of ergonomically designed laboratory ... Koki of Japan to sell and ... . NuAire will utilize its network of sales professionals throughout ... to offer assistance in application use, product benefits and ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... Sept. 16 Reportlinker.com announces that a new ... U.S. Market for Cardiac Rhythm ... http://www.reportlinker.com/p0294050/US-Market-for-Cardiac-Rhythm-Management-Electrophysiology-and-Ablation-Devices-2010.html In 2009, ... electrophysiology and ablation devices was valued at $7.63 ...
... American workers and job applicants are testing positive for prescription ... annual Drug Testing Index™ (DTI) released today by Quest Diagnostics ... of diagnostic testing, information and services. Results from ... percent jump in opiate positives in the general U.S. workforce ...
Cached Medicine Technology:Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 2Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 3Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 4Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 5Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 6Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 7Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 8Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 9Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 10Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 11Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 12Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 13Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 14Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 15Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 16Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 17Reportlinker Adds U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 18U.S. Worker Use of Prescription Opiates Climbing, Shows Quest Diagnostics Drug Testing Index™ 2U.S. Worker Use of Prescription Opiates Climbing, Shows Quest Diagnostics Drug Testing Index™ 3U.S. Worker Use of Prescription Opiates Climbing, Shows Quest Diagnostics Drug Testing Index™ 4U.S. Worker Use of Prescription Opiates Climbing, Shows Quest Diagnostics Drug Testing Index™ 5U.S. Worker Use of Prescription Opiates Climbing, Shows Quest Diagnostics Drug Testing Index™ 6
(Date:4/20/2014)... Researchers may have identified key genes linked to why ... others, according to a study released today that will ... Annual Meeting in Philadelphia, April 26 to May 3, ... it provides an objective way to understand pain and ... study author Tobore Onojjighofia, MD, MPH, with Proove Biosciences ...
(Date:4/18/2014)... online in The Gerontologist reports ... associated with a decrease in anxiety about death and ... over their lives. In particular, listening to gospel music ... and an increase in sense of control. , These ... men, and individuals of both low- and high-socioeconomic status. ...
(Date:4/18/2014)... Research Institute at Virginia Mason (BRI) recently received a ... metastatic breast cancer reduces both the growth of primary ... have found in models of the disease that blocking ... percent and can keep the tumor from metastasizing or ... comes from the National Cancer Institute of the National ...
(Date:4/18/2014)... scientists could lead to potential new treatments for breaking ... , Fibrosis, or scarring, is a hallmark of ... lungs can lead to serious organ damage and, in ... options centers on findings made by Swati Bhattacharyya, PhD, ... that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... targets that could be used to provide relief ... London made the discovery when researching how pain ... body. , Dr Marzia Malcangio said: "We have ... and our findings could help chemotherapy patients who ... side effect of some chemotherapy drugs (such as ...
Breaking Medicine News(10 mins):Health News:Low tolerance for pain? The reason may be in your genes 2Health News:Religious music brings benefit to seniors' mental health 2Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2
... , SCOTTSDALE, Ariz., Dec. 31 Healthcare ... estate investment trust, announced the completed acquisition of a ... Texas, Corsicana, Texas, and Fort Wayne, Indiana for approximately ... 100% leased to community hospitals that are wholly-owned subsidiaries ...
... It,s a fact: each and every January senior living communities see ... and answers as to how to best care for an aging ... time when adult children come face to face with the increasing ... national leader in senior assisted living and memory care communities, works ...
... LOS ANGELES, Dec. 31 Numbers are not just statistics. Sometimes ... the preceding century when lives became daily body counts in televised ... is certainly not the only organization whose staff have worked ... selfless staffs of all humanitarian groups and those individual human beings ...
... over steroid injections, researchers say , THURSDAY, Dec. 31 ... diabetes-related eye disease, though lasers remain the treatment of ... new research shows. , Researchers from the Johns Hopkins ... had diabetic retinopathy with macular edema either injections of ...
... ... a restaurant chain launched promotion that sold out in 90 minutes using online channel to ... ... closed, there were a handful that took the path less beaten and decided it was ...
... , , MILWAUKEE, Dec. 31 Step to the side of ... a partnership with America,s wellness expert Jillian Michaels to encourage women ... motorcycle. , Michaels, a life-long motorcycle enthusiast and licensed ... Party Month, which features a special promotion that will reward one ...
Cached Medicine News:Health News:Healthcare Trust of America, Inc. Acquires a 92,500 SF Medical Office Portfolio Located in Texas and Indiana 2Health News:Healthcare Trust of America, Inc. Acquires a 92,500 SF Medical Office Portfolio Located in Texas and Indiana 3Health News:After the Holidays Families Recognize Changing Needs of Aging Parents and Loved Ones 2Health News:After the Holidays Families Recognize Changing Needs of Aging Parents and Loved Ones 3Health News:Narconon Salutes Its 1,200 Staff Worldwide on 13,000 Lives Saved This Last Decade 2Health News:Narconon Salutes Its 1,200 Staff Worldwide on 13,000 Lives Saved This Last Decade 3Health News:Laser Deemed Best Treatment for Diabetic Retinopathy 2Health News:Small Businesses In Singapore Outmarkets & Outperforms Bigger Players in Tough Economy With Online Marketing 2Health News:TV Wellness Expert Jillian Michaels Teams With Harley-Davidson to Help Women Channel Their Inner Drive and Live More Fulfilling Lives 2Health News:TV Wellness Expert Jillian Michaels Teams With Harley-Davidson to Help Women Channel Their Inner Drive and Live More Fulfilling Lives 3Health News:TV Wellness Expert Jillian Michaels Teams With Harley-Davidson to Help Women Channel Their Inner Drive and Live More Fulfilling Lives 4
... The optimal combination of performance ... New 4x5 mL swinging bucket rotor. ... 0.2 ml to 8.3 ml, with ... drive, very quiet operation, rotor imbalance ...
... versatility, and environmental safety are ... LE-80 K Ultracentrifuge from Beckman ... Optima centrifugation technology, the LE-80 ... effectively provide advanced capability for ...
... power for small-volume samples. With the ability ... removing chylomicrons (fat particles in lipemic samples), ... lipemic clarification. Lipemic samples can be cleaned ... sendouts. The easy-to-operate tabletop centrifuge: Reaches ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
Medicine Products: